Therefore, the amelioration of inflammation and insulin resistance by SXT in liver of T2DM rats might contribute to activate insulin signaling cascades in skeletal muscle, which accounted for more than 80% of insulin induced glucose disposal in humans (Zierath et al., 1996). The gene discussed is INS; the disease is type 2 diabetes mellitus.